title: Dosing Penalty of Erythropoiesis-Stimulating Agents After Switching From Originator to Biosimilar Preparations in Stable Hemodialysis Patients.
authors.affiliation: Second University of Naples, Naples, Italy. Electronic address: roberto.minutolo@unina2.it.
authors.forename: Roberto
authors.initials: R
authors.lastname: Minutolo
authors.affiliation: Castelli Hospital, Verbania, Italy.
authors.forename: Maurizio
authors.initials: M
authors.lastname: Borzumati
authors.affiliation: SS Giacomo e Cristoforo Hospital, Massa, Italy.
authors.forename: Stefano
authors.initials: S
authors.lastname: Sposini
authors.affiliation: S Giacomo Apostolo Hospital, Castelfranco Veneto, Italy.
authors.forename: Cataldo
authors.initials: C
authors.lastname: Abaterusso
authors.affiliation: Padova Hospital, Padova, Italy.
authors.forename: Gianni
authors.initials: G
authors.lastname: Carraro
authors.affiliation: L Parodi Delfino Hospital, Colleferro, Italy.
authors.forename: Alberto
authors.initials: A
authors.lastname: Santoboni
authors.affiliation: Santa Maria alla Gruccia Hospital, Montevarchi, Italy.
authors.forename: Carlo
authors.initials: C
authors.lastname: Mura
authors.affiliation: Sant'Andrea Hospital, Vercelli, Italy.
authors.forename: Oliviero
authors.initials: O
authors.lastname: Filiberti
authors.affiliation: University of Messina, Messina, Italy.
authors.forename: Domenico
authors.initials: D
authors.lastname: Santoro
authors.affiliation: Castrovillari Hospital, Castrovillari, Italy.
authors.forename: Romano
authors.initials: R
authors.lastname: Musacchio
authors.affiliation: Arezzo Hospital, Arezzo, Italy.
authors.forename: Patrizio
authors.initials: P
authors.lastname: Imperiali
authors.affiliation: Rovigo Hospital, Rovigo, Italy.
authors.forename: Fulvio
authors.initials: F
authors.lastname: Fiorini
authors.affiliation: Second University of Naples, Naples, Italy.
authors.forename: Luca
authors.initials: L
authors.lastname: De Nicola
authors.affiliation: University "Federico II," Naples, Italy.
authors.forename: Domenico
authors.initials: D
authors.lastname: Russo
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D018798:Anemia, Iron-Deficiency / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D059451:Biosimilar Pharmaceuticals / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D057915:Drug Substitution; D000068817:Epoetin Alfa / Q000008:administration & dosage*; D004921:Erythropoietin / Q000008:administration & dosage*; D005260:Female; D006397:Hematinics / Q000008:administration & dosage*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007501:Iron / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage; D006435:Renal Dialysis; D012189:Retrospective Studies; D014131:Trace Elements / Q000627:therapeutic use
chemical_list: D059451:Biosimilar Pharmaceuticals; D006397:Hematinics; D006454:Hemoglobins; D011994:Recombinant Proteins; D014131:Trace Elements; C530192:epoetin zeta; D004921:Erythropoietin; D000068817:Epoetin Alfa; D007501:Iron